Twist Bioscience.
Biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 60
What's happening
Earlier this month
One to three months ago
-
Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Some support6 reports
-
VUG concentrates on large-cap leaders like Nvidia. VUG holds large-cap leaders such as Microsoft. VUG holds established giants including Apple. IWO holds small-cap equities including Twist Bioscience.Some support1 report
-
Twist Bioscience and BioLife Solutions are healthcare companies in the biotech sector listed on Nasdaq.Some support1 report
-
Corcept Therapeutics and Twist Bioscience are noted as holdings within the First Trust biotech fund.Some support1 report
Gone quiet
No new reports in 90+ days-
Sean McClain discusses the AI/biotech space, noting that Anthropic and Twist Bioscience operate in this sector.Some support1 report
-
Twist Bioscience underperformed the market so far this year, based on data from August 4, 2025.Some support2 reports
-
Paula Green sold shares of Twist Bioscience stock, and Millennium Management increased its holdings in the company on July 29, 2026.Some support2 reports
-
Thermo Fisher Scientific and Twist Bioscience benefit from Trump-era tariffs while operating in the life sciences sector.Some support1 report
-
Twist Bioscience filed disclosures with the SEC, listed its stock on Nasdaq, and received a rating upgrade from TD Cowen.Some support2 reports
-
Insider sold shares of Twist Bioscience stock on June 24, 2026.Some support1 report
-
Life sciences companies Danaher Corporation and Twist Bioscience are facing headwinds due to exposure to China and academic spending.Some support1 report
-
Twist Bioscience announced an accelerated Express turnaround time for all gene fragments.Speculative1 report
-
Twist Bioscience and LinkedIn were involved in an event on July 24, 2025.Some support1 report
-
Conestoga Capital Advisors highlighted Twist Bioscience in its investor letter on July 28, 2025.Some support1 report
-
Twist Bioscience launched its HuTg model to expand antibody discovery services and complement existing in vivo platforms.Some support1 report
-
Twist Bioscience is based in South San Francisco.Some support2 reports
-
Twist Bioscience reported revenue growth compared to the industry average and its technology is noted for potentially replacing current computers.Some support2 reports
-
Twist Bioscience's RSI reading indicates heavy selling is exhausting itself, coinciding with analysts raising earnings estimates.Some support1 report
-
Twist Bioscience launched an Oncology DNA Comprehensive Genomic Profiling (CGP) Panel on August 19, 2025.Some support1 report
-
Twist Bioscience hosted a conference in New York City on September 3, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Twist Bioscience this week
News at the entities that move Twist Bioscience most-
SEC StructuralMSCI index rules may affect Bitcoin companies, while warnings caused stock market crashes in Turkey and Indonesia.Moves Twist Bioscience
-
TD Cowen OperationalTD Cowen is based in Toronto.Moves Twist Bioscience
-
Nasdaq StructuralGolub Capital BDC, Inc. listed on the electronic stock exchange.Moves Twist Bioscience
-
Eli Lilly and Company OperationalSiemens Healthineers is undergoing deconsolidation from Siemens, while Gallup data shows rising demand for obesity drugs and Lilly treatments are FDA-approved.Moves Twist Bioscience
-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves Twist Bioscience
-
Ark Invest TransactionalArk Invest and BlackRock are partnering with tokenization specialist Securitize, with their assets being tracked in options markets.Moves Twist Bioscience
Connections
The 23 strongest of 60, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Emily Leproust Structural
Emily Leproust serves as the CEO of Twist Bioscience, managing company strategy and executing stock sales.
-
SEC Structural
Twist Bioscience is subject to formal disclosure and regulatory requirements imposed by the SEC.
-
Paula Green Structural
Paula Green serves as the Senior Vice President of Twist Bioscience and trades its stock.
-
Nasdaq Structural
Twist Bioscience is formally listed and trades on the Nasdaq stock exchange.
-
TD Cowen Operational
TD Cowen issues financial ratings and target price recommendations for Twist Bioscience.
-
Element Biosciences Operational
Element Biosciences and Twist Bioscience are collaborating on NGS tools, with Twist supplying exclusive library prep and enrichment kits.
-
Millennium Management Transactional
Millennium Management increased its holdings in Twist Bioscience.
-
Eli Lilly and Company Operational
Twist Bioscience and Eli Lilly have established a data services agreement to accelerate drug development.
Show all 23 connections
-
Ark Invest Transactional
Ark Invest executed a divestment by cutting its investment stake in Twist Bioscience as part of portfolio rebalancing.
-
MarketBeat Mentioned together
MarketBeat provides consensus ratings and target price information for Twist Bioscience.
-
Benzinga Operational
Twist Bioscience utilizes Benzinga's platform to disseminate company news and market updates.
-
Twist Structural
Twist is identified as an insider who sold shares of Twist Bioscience stock.
-
Leerink partners Mentioned together
The relationship is characterized by shared market analyst coverage, specifically regarding price targets.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group initiated investment coverage on Twist Bioscience.
-
Anthropic Mentioned together
The entities are co-mentioned as operating within the shared AI and biotech sectors and are subject to similar market dynamics.
-
Danaher Corporation Operational
The entities are identified as competitors operating within the life sciences sector.
-
Barclays Mentioned together
Barclays issued a price target on Twist Bioscience.
-
Tempus Mentioned together
Both companies are noted to operate within the precision medicine and biotech sectors.
-
ISI Mentioned together
Both ISI and Twist Bioscience are covered by the same analyst firm, leading to target price adjustments.
-
LinkedIn Shared context
Twist Bioscience utilizes LinkedIn for professional networking and social media presence.
-
Thermo Fisher Scientific Inc. Shared context
The two companies share the life sciences sector as their operational context.
-
Corcept Therapeutics Mentioned together
Both companies are mentioned as holdings within various biotech investment funds.
-
SynBio Mentioned together
The evidence provided does not describe any relationship or interaction between Twist Bioscience and SynBio.
History
Events by the month they beganNovember 2026
1 eventSeptember 2026
2 events- VUG concentrates on large-cap leaders like Nvidia. VUG holds large-cap leaders such as Microsoft. VUG holds established giants including Apple. IWO holds small-cap equities including Twist Bioscience.
- Twist Bioscience and BioLife Solutions are healthcare companies in the biotech sector listed on Nasdaq.
August 2026
2 eventsShow 2 earlier months
July 2026
2 eventsJune 2026
15 events- Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.
- Twist Bioscience underperformed the market so far this year, based on data from August 4, 2025.
- Thermo Fisher Scientific and Twist Bioscience benefit from Trump-era tariffs while operating in the life sciences sector.
- Twist Bioscience filed disclosures with the SEC, listed its stock on Nasdaq, and received a rating upgrade from TD Cowen.
- Insider sold shares of Twist Bioscience stock on June 24, 2026.
- Life sciences companies Danaher Corporation and Twist Bioscience are facing headwinds due to exposure to China and academic spending.
- Twist Bioscience announced an accelerated Express turnaround time for all gene fragments.
- Twist Bioscience and LinkedIn were involved in an event on July 24, 2025.
- Conestoga Capital Advisors highlighted Twist Bioscience in its investor letter on July 28, 2025.
- Twist Bioscience launched its HuTg model to expand antibody discovery services and complement existing in vivo platforms.
- Twist Bioscience is based in South San Francisco.
- Twist Bioscience reported revenue growth compared to the industry average and its technology is noted for potentially replacing current computers.
- Twist Bioscience's RSI reading indicates heavy selling is exhausting itself, coinciding with analysts raising earnings estimates.
- Twist Bioscience launched an Oncology DNA Comprehensive Genomic Profiling (CGP) Panel on August 19, 2025.
- Twist Bioscience hosted a conference in New York City on September 3, 2025.